Initially identified as a solid malignancy CSC marker in breast cancer [18], Prince et al. demonstrated that CD44 expression could also be used to isolate a tumor subpopulation with increased tumorigenicity in HNSCC [23]. Here, CD44 is linked to neoplasm.